ARTICLE | Company News
Depomed deal
January 22, 2001 8:00 AM UTC
DMI and an undisclosed pharmaceutical partner will develop a controlled release formulation of a marketed product using a DMI drug delivery technology. The partner will make an initial payment to DMI ...